Boston, Massachusetts, United States
Senior level executive with professional experience across the Big 4, corporate industry, and tech-startup industries. Expertise in helping leadership teams implement value creation/capture strategies. A domain expert in the HealthTech market with extensive leadership experience in strategic planning and corporate development activities including M&A, carveouts, and corporate restructuring.
* Senior executive assisting clients with M&A strategy, due diligence, integration planning, & integration management office * Healthcare Technology, Pharmaceutical, and Life Sciences
Heart Disease is the #1 cause of death in the world. Corventive (a TechStars company) provides predictive AI technology which can identify +10% more patients at-risk of cardiovascular disease within existing populations. Corventive validated its technologies under commercial contracts with health provider customers - Over 65% of patients identified by the Corventive AI were diagnosed with coronary artery disease with more than half of the patients at high risk for a heart attack within 3 to 5 years.
World’s leading accelerator and most active pre-seed investor having invested in +4,000 early-stage startups with a cumulative market capitalization of +$113B. As a portfolio company, Corventive received pre-seed investment capital and participated in the on-site, summer cohort class (12 startups) to accelerate innovative tech companies * Worked extensively with the program and other startup founders on Go-To-Market and investor readiness * Corventive’s Demo Day pitch, live @ the House of Blues, garnered significant interest from the venture capital & angel investor community:
Responsible for division wide strategic planning and mergers & acquisitions efforts that further the Wolters Kluwer Health division’s (+$1B in revenue) strategic growth objectives. Core technology-enabled products include: UpToDate, Ovid, and Lippincott Williams & Wilkins medical/nursing on-line books & journals. * Led the annual Vision & Strategic Planning (VSP) process for the Health division. * Led numerous Business Unit and cross Business Unit strategy projects that led to formal business strategy development, product strategy execution, and business goal realignment. Projects encompassed the strategic planning lifecycle including: (i.) conducting both primary and secondary market research including customer interviews & surveys; and (ii.) market segmentation analysis including in depth studies on customer budgets, content use cases, and buying patterns. * Led the initial assessment of several $100M+ domestic and international acquisitions
Responsible for strategic partnerships and mergers & acquisitions execution including identifying, sourcing, and evaluating targets that furthered the growth objectives of the Health & Science Division (+$1B in revenue). Core technology-enabled products include: Clinical Key, MD Consult, and Nursing Consult.